203 related articles for article (PubMed ID: 7721389)
1. Effect of chronic treatment of adult spontaneously hypertensive rats with an endothelin receptor antagonist.
Li JS; Schiffrin EL
Hypertension; 1995 Apr; 25(4 Pt 1):495-500. PubMed ID: 7721389
[TBL] [Abstract][Full Text] [Related]
2. Chronic endothelin receptor antagonist treatment of young spontaneously hypertensive rats.
Li JS; Schiffrin EL
J Hypertens; 1995 Jun; 13(6):647-52. PubMed ID: 7594422
[TBL] [Abstract][Full Text] [Related]
3. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats.
Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T
Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194
[TBL] [Abstract][Full Text] [Related]
4. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats.
Li JS; Schürch W; Schiffrin EL
Am J Hypertens; 1996 Aug; 9(8):803-11. PubMed ID: 8862227
[TBL] [Abstract][Full Text] [Related]
5. Comparison of effect of endothelin antagonism and angiotensin-converting enzyme inhibition on blood pressure and vascular structure in spontaneously hypertensive rats treated with N omega-nitro-L-arginine methyl ester. Correlation with topography of vascular endothelin-1 gene expression.
Li JS; Deng LY; Grove K; Deschepper CF; Schiffrin EL
Hypertension; 1996 Aug; 28(2):188-95. PubMed ID: 8707380
[TBL] [Abstract][Full Text] [Related]
6. Effect of a nonselective endothelin antagonist on vascular remodeling in deoxycorticosterone acetate-salt hypertensive rats. Evidence for a role of endothelin in vascular hypertrophy.
Li JS; Larivière R; Schiffrin EL
Hypertension; 1994 Aug; 24(2):183-8. PubMed ID: 8039842
[TBL] [Abstract][Full Text] [Related]
7. Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats.
Sventek P; Li JS; Grove K; Deschepper CF; Schiffrin EL
Hypertension; 1996 Jan; 27(1):49-55. PubMed ID: 8591887
[TBL] [Abstract][Full Text] [Related]
8. Effect of AT1 angiotensin-receptor blockade on structure and function of small arteries in SHR.
Li JS; Sharifi AM; Schiffrin EL
J Cardiovasc Pharmacol; 1997 Jul; 30(1):75-83. PubMed ID: 9268224
[TBL] [Abstract][Full Text] [Related]
9. ETA and ETB receptors mediate contraction to endothelin-1 in renal artery of aging SHR. Effects of FR139317 and bosentan.
Seo B; Lüscher TF
Hypertension; 1995 Apr; 25(4 Pt 1):501-6. PubMed ID: 7721390
[TBL] [Abstract][Full Text] [Related]
10. Calcium sensitivity and agonist-induced calcium sensitization in small arteries of young and adult spontaneously hypertensive rats.
Shaw LM; Ohanian J; Heagerty AM
Hypertension; 1997 Sep; 30(3 Pt 1):442-8. PubMed ID: 9314430
[TBL] [Abstract][Full Text] [Related]
11. Enhanced expression of endothelin-1 gene may cause blood pressure-independent vascular hypertrophy.
Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
J Cardiovasc Pharmacol; 1995; 26 Suppl 3():S5-8. PubMed ID: 8587458
[TBL] [Abstract][Full Text] [Related]
12. Effect of chronic treatment with two different ET(A) selective endothelin receptor antagonists on blood pressure and small artery structure of deoxycorticosterone acetate (DOCA)-salt hypertensive rats.
Li JS; Turgeon A; Schiffrin EL
Am J Hypertens; 1998 May; 11(5):554-62. PubMed ID: 9633791
[TBL] [Abstract][Full Text] [Related]
13. Endothelin-1 expression in blood vessels of DOCA-salt hypertensive rats treated with the combined ETA/ETB endothelin receptor antagonist bosentan.
Larivière R; Sventek P; Thibault G; Schiffrin EL
Can J Physiol Pharmacol; 1995 Mar; 73(3):390-8. PubMed ID: 7544236
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1 gene expression and vascular hypertrophy in DOCA-salt hypertension compared to spontaneously hypertensive rats.
Schiffrin EL; Lariviere R; Li JS; Sventek P; Touyz RM
Clin Exp Pharmacol Physiol Suppl; 1995 Dec; 22(1):S188-90. PubMed ID: 9072349
[TBL] [Abstract][Full Text] [Related]
15. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats.
Schiffrin EL; Turgeon A; Deng LY
Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550
[TBL] [Abstract][Full Text] [Related]
16. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats.
Hocher B; Rohmeiss P; Zart R; Diekmann F; Vogt V; Metz D; Fakhury M; Gretz N; Bauer C; Koppenhagen K; Neumayer HH; Distler A
Cardiovasc Res; 1996 Apr; 31(4):499-510. PubMed ID: 8689641
[TBL] [Abstract][Full Text] [Related]
17. Deoxycorticosterone acetate plus salt induces overexpression of vascular endothelin-1 and severe vascular hypertrophy in spontaneously hypertensive rats.
Schiffrin EL; Larivière R; Li JS; Sventek P; Touyz RM
Hypertension; 1995 Apr; 25(4 Pt 2):769-73. PubMed ID: 7721430
[TBL] [Abstract][Full Text] [Related]
18. Contractile responses and signal transduction of endothelin-1 in aorta and mesenteric vasculature of adult spontaneously hypertensive rats.
Nguyen PV; Yang XP; Li G; Deng LY; Flückiger JP; Schiffrin EL
Can J Physiol Pharmacol; 1993 Jul; 71(7):473-83. PubMed ID: 8242481
[TBL] [Abstract][Full Text] [Related]
19. Endothelin antagonism in end-organ damage of spontaneously hypertensive rats. Comparison with angiotensin-converting enzyme inhibition and calcium antagonism.
Karam H; Heudes D; Bruneval P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
Hypertension; 1996 Sep; 28(3):379-85. PubMed ID: 8794820
[TBL] [Abstract][Full Text] [Related]
20. Effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist, and an endothelin receptor antagonist on renal afferent arteriolar structure.
Skov K; Fenger-Grøn J; Mulvany MJ
Hypertension; 1996 Sep; 28(3):464-71. PubMed ID: 8794834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
